Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming
PubMed Full text in PMC Similar studies Analyze with GEO2R
NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming [Transduction]
NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming [TKO]
NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming [RNAi]
NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming [ChIP]
PubMed Full text in PMC Similar studies SRA Run Selector
NSD2 interacts with SMARCA2 and regulates expression of oncogenes CCND1 and PRL3 in t(4;14) multiple myeloma
PubMed Similar studies Analyze with GEO2RSRA Run Selector
MMSET Induces Global and Focal Changes in Histone Methylation in Myeloma Cells
MMSET regulation of gene expression in t(4;14)+ myeloma
MMSET alters EZH2 Binding in Myeloma Cells
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Histone methyltransferase MMSET overexpression effect on KMS11 multiple myeloma cell line
PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet
Targeting steroid receptor co-activator 3 sensitizes myeloma cell to proteasome inhibitor treatment through NSD2-mediated phase separation and chromatin remodeling
PubMed Full text in PMC Similar studies
Targeting steroid receptor co-activator 3 sensitizes myeloma cell to proteasome inhibitor treatment through NSD2-mediated phase separation and chromatin remodeling [RNA-Seq]
Targeting steroid receptor co-activator 3 sensitizes myeloma cell to proteasome inhibitor treatment through NSD2-mediated phase separation and chromatin remodeling [ChIP-Seq]
Effects of NSD2 depletion on gene expression and H3K36me2 in a lung cancer cell line
Effects of MMSET on gene expression in multiple myeloma
Nuclear TIGAR mediates an epigenetic-metabolic loop via Nrf2 for cancer therapeutics resistance
ASH1L links histone H3 lysine 36 di-methylation to leukemia
NSD2 amplifies oncogenic transcriptional output to promote lung adenocarcinoma pathogenesis
NSD2 amplifies oncogenic transcriptional output to promote lung adenocarcinoma pathogenesis [RNA-seq]
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on